Literature DB >> 16799238

Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy.

Chitose Ishikawa1, Takayoshi Tsutamoto, Masanori Fujii, Hiroshi Sakai, Toshinari Tanaka, Minoru Horie.   

Abstract

BACKGROUND: The prognostic role of serum C-reactive protein (CRP) in chronic heart failure (CHF) patients, especially those with nonischemic dilated cardiomyopathy (DCM), remains unknown. In the present study, whether CRP provides prognostic information in DCM patients was evaluated. METHODS AND
RESULTS: Neurohumoral factors and hemodynamics in 84 consecutive DCM patients were measured and these patients were followed up for a mean period of 42 months. During the follow-up period, 23 patients developed cardiac events and 18 patients died of cardiac causes. Using stepwise multivariate Cox proportional hazards regression analyses, log brain natriuretic peptide (BNP) (p = 0.007) and high-sensitivity CRP (hsCRP) > 1 mg/L (p = 0.008) were significant independent predictors of cardiac events. The patients were stratified into 4 groups based on the normal serum concentration of hsCRP (1 mg/L) and median plasma concentration of BNP (110 pg/ml). Survival rates were significantly higher in patients with hsCRP < 1 mg/L and BNP < 110 pg/ml. The hazard ratio of patients with BNP > 110 pg/ml and hsCRP > 1 mg/L was 15.8 (95% confidence interval, 1.9-127.2) compared with those with BNP < 110 pg/ml and hsCRP < 1 mg/L for cardiac death.
CONCLUSIONS: Serum hsCRP level is an independent prognostic predictor in patients with DCM and the combination of hsCRP and BNP may be useful for the management of CHF patients with DCM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16799238     DOI: 10.1253/circj.70.857

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  11 in total

1.  Association between C-reactive protein levels at hospital admission and long-term mortality in patients with acute decompensated heart failure.

Authors:  Hiroki Matsumoto; Takatoshi Kasai; Akihiro Sato; Sayaki Ishiwata; Shoichiro Yatsu; Jun Shitara; Azusa Murata; Takao Kato; Shoko Suda; Yuya Matsue; Masaru Hiki; Atsutoshi Takagi; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2019-05-18       Impact factor: 2.037

2.  The relationship among brain natriuretic peptide (BNP), cholesterol and lipoprotein.

Authors:  Hidekazu Takeuchi; Masataka Sata
Journal:  Heart Asia       Date:  2012-01-01

3.  Higher C-reactive protein predicts worse prognosis in acute heart failure only in noninfected patients.

Authors:  Patrícia Lourenço; José Paulo Araújo; Cristiana Paulo; Joana Mascarenhas; Fernando Friões; Ana Azevedo; Paulo Bettencourt
Journal:  Clin Cardiol       Date:  2010-11       Impact factor: 2.882

4.  Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction.

Authors:  Natale Daniele Brunetti; Pier Luigi Pellegrino; Michele Correale; Luisa De Gennaro; Andrea Cuculo; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2007-11-24       Impact factor: 2.300

5.  Systemic inflammation in nonischemic dilated cardiomyopathy.

Authors:  Luisa De Gennaro; Natale Daniele Brunetti; Andrea Cuculo; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  Heart Vessels       Date:  2008-11-27       Impact factor: 2.037

6.  Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy.

Authors:  Kapka Miteva; Sophie Van Linthout; Hans-Dieter Volk; Carsten Tschöpe
Journal:  Stem Cells Int       Date:  2013-06-19       Impact factor: 5.443

7.  The effects of levosimendan use on high-sensitivity C-reactive protein in patients with decompensated heart failure.

Authors:  Hasan Korkmaz; Mücahid Yilmaz
Journal:  Arch Med Sci Atheroscler Dis       Date:  2019-07-22

8.  Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes.

Authors:  Yuxiao Hu; Jie Ren; Xueqi Dong; Di Zhang; Yi Qu; Chunxue Yang; Yang Sun; Jinghui Li; Fang Luo; Wei Wang; Huanhuan Wang; Ping Qing; Shihua Zhao; Jie Huang; Litian Yu; Yaxin Liu; Huiqiong Tan
Journal:  Front Cardiovasc Med       Date:  2021-12-03

9.  Combined use of brain natriuretic peptide and C-reactive protein for predicting cardiovascular risk in outpatients with type 2 diabetes mellitus.

Authors:  Toshihiro Tsuruda; Johji Kato; Takahiro Sumi; Kazuya Mishima; Hiroyuki Masuyama; Hiroyuki Nakao; Takuroh Imamura; Tanenao Eto; Kazuo Kitamura
Journal:  Vasc Health Risk Manag       Date:  2007

10.  Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure?

Authors:  Joana Pereira; Ana Ribeiro; João Ferreira-Coimbra; Isaac Barroso; João-Tiago Guimarães; Paulo Bettencourt; Patrícia Lourenço
Journal:  BMC Cardiovasc Disord       Date:  2018-02-27       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.